Related Experiment Videos
Non-proteolytic, receptor/ligand interactions associate cellular membrane type-1 matrix metalloproteinase with the
Dmitri V Rozanov1, Sergey Sikora, Adam Godzik
1Burnham Institute, La Jolla, California 92037, USA.
The Journal of Biological Chemistry
|September 18, 2004
Summary
Membrane type-1 matrix metalloproteinase (MT1-MMP) binds C1q, a key immune protein. This interaction, involving specific peptide sequences, is independent of MT1-MMP’s enzymatic activity and offers new insights into cancer biology.
Area of Science:
- Biochemistry
- Immunology
- Molecular Biology
Background:
- Membrane type-1 matrix metalloproteinase (MT1-MMP) is crucial for cellular proteolysis.
- MT1-MMP recognizes and cleaves protein targets, playing a role in various biological processes.
Purpose of the Study:
- To investigate the interaction between MT1-MMP and C1q, the recognition unit of the complement system.
- To identify the specific regions of MT1-MMP involved in C1q binding.
Main Methods:
- In silico modeling to predict binding sites.
- Site-directed mutagenesis to confirm peptide involvement.
- In vitro and cell-based binding assays to validate interactions.
Main Results:
- MT1-MMP and related membrane MMPs bind to C1q.
- Binding involves the catalytic domain of MT1-MMP and the globular domain of C1q.
- Specific peptide sequences (His(171)-Glu-Lys-Gln-Ala-Asp(176) and Val(223)-Arg-Asn(224)) in MT1-MMP mediate C1q binding.
- Both active and latent forms of MT1-MMP bind C1q.
- C1q is resistant to MT1-MMP proteolysis.
Conclusions:
- MT1-MMP engages in unconventional, receptor/ligand-like interactions with C1q.
- These findings expand the understanding of MT1-MMP's function beyond proteolysis.
- The interaction may have significant implications for the role of MT1-MMP in immunity and cancer.